ROXBURY TWP. - Vowing continued fiscal austerity coupled with counted on reliable services, Republican Jacqueline "Jaki" Albrecht has been chosen to serve as mayor for 2024.
Police say a 69-year-old Georgia woman passed signs on Interstate 78 eastbound in Berks County warning of a lane closure near Hamburg, as well as one that implored drivers to “Save a Life Slow Down in Work Zones” before setting off a multivehicle crash.
ProTom International Announces Strategic Agreement with the Behnke Group to Enhance U.S. Market Presence prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Eventbrite s fee is nonrefundable.
Event description
The first of its kind in Australia, the Australian Bragg Centre will provide next-generation cancer treatment to children and adults. About this Event
This IHEA Professional Development event will be delivered by two leading speakers in the field – Mr Stephen Spotts, Protom CEO, and Dr Ben Saxon, WCHN Head of Paediatric Haematology and Oncology.
Speakers
Mr Stephen Spotts, CEO of ProTom will speak about the ProTom technology and his commitment to increasing access to proton therapy technology. Like many families, his family has been affected by cancer. Mr. Spotts believes proton therapy should be available to all patients who would benefit from it. Mr. Spotts will also give some insights into the challenges of constructing a building to accommodate the technology.
ProTom International Signed a Strategic Distribution and Licensing Agreement to Distribute with GHGK in China
News provided by
Share this article
Share this article
WAKEFIELD, Mass., Jan. 11, 2021 /PRNewswire/ ProTom International Holding Corporation ( ProTom ) is pleased to announce that it has signed a distribution and licensing agreement with Guohong Guokang (Beijing) Health Technology Development Co., LTD ( GHGK ) who, along with its affiliates, is one of the leading comprehensive high-tech innovative enterprises in China for an exclusive distribution and licensing Agreement to distribute ProTom s Radiance 330® Proton Therapy System in mainland China. The signing of this agreement marks an important milestone for improving the clinical outcomes of cancer patients in China and the